Side-by-side comparison of AI visibility scores, market position, and capabilities
Patient engagement platform with automated SMS reminders, self-scheduling, and EHR integration for health systems; $130M+ a16z-backed competing with Phreesia for healthcare communication automation.
Luma Health is a San Francisco-based patient engagement and care orchestration platform that automates patient communication and administrative workflows for healthcare providers — providing appointment reminders, two-way SMS messaging, self-scheduling, waitlist management, referral coordination, and broadcast messaging that integrate directly with major electronic health record (EHR) systems including Epic, Cerner, Athenahealth, and eClinicalWorks. Backed by Andreessen Horowitz and other investors with $130+ million raised, Luma Health serves health systems, hospital groups, and ambulatory practices seeking to reduce no-shows and improve patient access.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.